Stocks and Investing Stocks and Investing
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013

Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $91 on, Apr 22nd, 2013


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-91-on-apr-22nd-2013.html
Published in Stocks and Investing on Friday, October 25th 2024 at 2:29 GMT by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $45 to $91 on, Apr 22nd, 2013.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $54 on, Wednesday, January 2nd, 2013

Publication Contributing Sources